This inventor holds 3 USPTO granted patents. Top assignees: Merck Sharp + Dohme Corp., Merck Frosst Canada & Co.. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bishops Stortford, GB (2006 - 2008)
- Stanstead, GB (2008)
Company Filing History:
3 out of 2,405 
1 out of 80 Years Active: 2006-2008
Title: The Innovative Contributions of Joanne Claire Hannam
Introduction
Joanne Claire Hannam is a notable inventor based in Stanstead, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target gamma-secretase, which is crucial in the treatment of Alzheimer's disease. With a total of 3 patents to her name, her work has the potential to impact many lives.
Latest Patents
Hannam's latest patents include innovative compounds that serve as inhibitors of gamma-secretase. One of her notable inventions is the "Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase." This patent discloses compounds of a specific formula, wherein R is an alkenyl group of defined structure. These compounds are particularly useful in the treatment of Alzheimer's disease. Another significant patent is for "Sulphonamido-substituted bridged bicycloalkyl derivatives." This class of compounds comprises sulphonamido-substituted bridged bicycloalkyl structures, which also act as inhibitors of gamma-secretase, aiding in the treatment and prevention of Alzheimer's disease.
Career Highlights
Throughout her career, Hannam has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corp. and Merck Frosst Canada & Co. Her experience in these organizations has allowed her to develop her innovative ideas into practical applications.
Collaborations
Hannam has collaborated with several professionals in her field, including Timothy Harrison and Andrew Madin. These collaborations have likely contributed to her success and the advancement of her research.
Conclusion
Joanne Claire Hannam's work exemplifies the impact of innovation in the pharmaceutical industry. Her patents not only showcase her creativity but also her commitment to addressing critical health issues such as Alzheimer's disease. Her contributions are a testament to the importance of research and development in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile